Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors
Joshua D. Bernstock, Asim K. Bag, John Fiveash, Kara Kachurak, Galal Elsayed, Gustavo Chagoya, Florian Gessler, Pablo A. Valdes, Avi Madan-Swain, Richard Whitley, James M. Markert, G. Yancey Gillespie, James M. Johnston, Gregory K. Friedman
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors'. Together they form a unique fingerprint.